Potential Disease-Modifying Effects of Lithium Carbonate in Niemann-Pick Disease, Type C1

Background: Niemann-Pick disease type C1 (NP-C1) is a rare, autosomal-recessive neurodegenerative disorder with no United States Food and Drug Administration (FDA)-approved drug. Lithium has been shown to have considerable neuroprotective effects for neurological disorders such as bipolar disorder,...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Shiqian, Zhang, Huiwen, Yi, Mengni, Liu, Xiaoqing, Maegawa, Gustavo H. B., Zou, Yunding, Wang, Qijun, Wu, Dianqing, Ye, Zhijia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220070/
https://www.ncbi.nlm.nih.gov/pubmed/34177581
http://dx.doi.org/10.3389/fphar.2021.667361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220070/
https://www.ncbi.nlm.nih.gov/pubmed/34177581
http://dx.doi.org/10.3389/fphar.2021.667361

Ejemplares similares